Page 8 - MemoriaBBN-Eng

ORGANIZATION

Manuel Monleón
Universidad Politécnica de Valencia
Comm. of Valencia

Isabel Obieta
Fundación TECNALIA
Basque Country

Javier Pavía
Universidad de Barcelona
Catalonia

José Luis Pedraz
Universidad del País Vasco
Basque Country

Soledad Penadés
CIC biomaGUNE
Basque Country

José Luis Peris
Instituto de Biomecánica de Valencia
Comm. of Valencia

Félix Ritort
Universidad de Barcelona
Catalonia

Laura Roa
Universidad de Sevilla
Andalusia

José C. Rodríguez
Universidad de Valladolid
Castile and Leon

Cristina Ruiz
úóíÁServicio Gallego de Salud - Hsp. Juan Canalejo
Galicia
éá
Josep Samitier
Instituto de Bioingeniería de Cataluña
Catalonia

ó
Julio San Román
CSIC
Madrid

Jess Santamaría
Universidad de Zaragoza
Aragón
ñ
Andrs Santos
íUniversidad Politécnica de Madrid
Madrid

Fausto Sanz
Universidad de Barcelona
Catalonia

Sim Schwartz
Inst. Catalán de Salud - Hospital Vall d’Hebron
Catalonia

Concepcin Solans
CSIC
Catalonia

Mara Vallet-Reg
Universidad Complutense de Madrid
Madrid

Jaume Veciana
CSIC
Catalonia

Nuria Vilaboa
Servicio Madrileño de Salud / Hospital La Paz
Madrid

Antonio Villaverde
Universidad Autónoma de Barcelona
ñCatalonia

Ma ngeles Muoz Servicio Madrileo de Salud - Hospital General
Madrid
Fernndez(*)
Universitario Gregorio Marañón

Daniel Navajas(*)
Universidad de Barcelona
Catalonia

Research groups forming CIBER-BBN. (*) Associated groups

Like other CIBERs, CIBER in Bioengineering, Biomaterials and Nanomedicine is legally
Organizational
classified as a consortium among the different participating institutions. The basic and
Structure of
functional units of CIBER-BBN are the research groups. In addition, CIBER-BBN also
Ciber and has governing bodies and operating bodies, as established in the Articles of Association.

its Technical According to the Articles of Association, CIBER-BBN has governing and steering bodies 13
20
Office
(Board of Trustees, Permanent Commission and Scientific Director), supporting and T
R
advisory bodies (External Scientific Advisory Committee and Steering Committee) and PO
administrative management bodies (Managing Director).
E
L R
The Board of Trustees is the maximum decision-making body in the consortium, and A
NU
consists of three representatives from the ISCIII (Instituto de Salud Carlos III) and N
one institucional representative from each of the consortium institutions. It is chaired A
/
by the Director of ISCIII and meets on a six-month basis.
BN
B
R-
BE
CI

8